#None #Clinical Chemistry #IVD Market #Kalorama

Kalorama Releases 2025 IVD Market Update

Kalorama Information, a prominent authority in in vitro diagnostics (IVD) market data, has recently published its latest In Vitro Diagnostic (IVD) Trends and Market Update for 2025. This update, divided into two detailed volumes, was first published in April 2025 and the second one is set for release in the fourth quarter of the year. Designed to provide a comprehensive and data-driven analysis, this report presents a snapshot of the evolving IVD market landscape, updating stakeholders on crucial trends between Kalorama's annual flagship publications, which include the widely referenced Worldwide Market for In Vitro Diagnostics report.

Overview of Kalorama's Expertise

For over two decades, Kalorama Information has earned a reputation as a reliable source of healthcare market research focusing solely on in vitro diagnostics, medical devices, gene sequencing, cell therapy, and pharmaceuticals. With a commitment to high-quality research and innovative analysis, Kalorama equips industry leaders and media with the insights necessary for informed decision-making in a constantly shifting economic environment.

Adapting to a Changing Market

As the IVD market encounters global economic fluctuations, diminishing COVID-19 revenue sources, and an upsurge in diagnostic innovations, the 2025 market update provides critical insights for industry stakeholders adapting to these changes. The report addresses key growth areas, including point-of-care diabetes testing, nucleic acid assays, gene testing, companion diagnostics, mass spectrometry, and HPV molecular diagnostics.

Mary Anne Crandall, Senior Market Analyst at Kalorama, remarked, "Despite the drop in revenues stemming from COVID-19 testing, we have observed a resurgence in certain areas such as clinical chemistry, immunoassays, and molecular diagnostics. The adoption of advanced technologies like nucleic acid assays and continuous glucose monitoring is particularly noteworthy."

Key Findings from the 2025 Report

The report reveals several significant trends:

• - Rapid Growth in Point-of-Care (POC) Segment: There has been robust growth observed in POC diagnostics during the fourth quarter of 2024.
• - Hematology Market Expansion: The hematology segment marked a 6% growth in the fourth quarter of 2024 compared to the previous quarter.
• - Surge in Molecular Diagnostics: Areas such as HPV molecular testing and nucleic acid assays experienced impressive double-digit year-over-year increases.
• - Cautious Market Momentum: While most sectors within IVD reported growth in 2024, a slight slowdown was noted in the fourth quarter compared to earlier quarters.

A Valuable Resource for Industry Players

Krishna's 2025 IVD market report is structured to serve as a strategic resource for:

• - IVD and medical device manufacturers
• - Investors focused on diagnostics and merger/acquisition teams
• - Directors and leaders in clinical laboratories and scientific affairs
• - Strategic planners, product managers, and regulatory professionals

Industry players can utilize the insights from this analysis to guide product development, adapt market strategies, and benchmark against competitors, while remaining prepared for regulatory and reimbursement fluctuations.

Purchase and Additional Information

For those interested, the In Vitro Diagnostic (IVD) Trends and Market Update, 2025 is now available for purchase. Kalorama Information, a valuable component of Science and Medicine Group Inc., has remained dedicated to delivering detailed and reliable market research that caters to a diverse array of healthcare sectors. Over the years, it has established itself as the go-to source for accurate insights into the U.S. and global medical markets. You can find more extensive analyses on topics ranging from biotechnology to clinical diagnostics on their website. Kalorama continues to influence informed decision-making through a commitment to evidence-based research in healthcare, actively shaping the industry's future.

For further details, visit Kalorama's official website.